Laetitia Bigger

Laetitia Bigger leads IFPMA’s efforts on vaccine policy and advocacy to encourage pharmaceutical innovation and improve people’s health and wellbeing around the world.
She oversees the Vaccines Committee, the interface between IFPMA members and international public health organizations involved in global immunization, which promotes sustainable policies and initiatives to support vaccine innovation and access to vaccines globally. Prior to joining IFPMA, Laetitia worked as a clinical research associate for the multidisciplinary center on oncology at the University Hospital Lausanne. She has a PhD in Molecular Biology from the University of Lausanne, Switzerland.